• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于时依模型的膀胱癌非肌层浸润患者膀胱颈部侵犯与复发的相关性分析

Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model.

机构信息

Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.

Department of Urology, Tama-Nambu Chiiki Hospital, Tokyo, Japan.

出版信息

Clin Genitourin Cancer. 2020 Apr;18(2):e62-e70. doi: 10.1016/j.clgc.2019.10.005. Epub 2019 Oct 16.

DOI:10.1016/j.clgc.2019.10.005
PMID:31744700
Abstract

BACKGROUND

Tumor location in bladder neck has reported to be a prognostic factor for non-muscle-invasive bladder cancer (NMIBC). We investigated the impact of bladder neck involvement (BNI) on recurrence in NMIBC using time-dependent covariate analysis.

PATIENTS AND METHODS

We enrolled 585 Japanese patients who underwent transurethral resection for bladder tumors at a single center from 2000 to 2016 and were pathologically diagnosed with Ta and T1 NMIBC. Each patient at each recurrence was assigned to a separate time-dependent stratum with its own baseline hazard function according to the Prentice-Williams-Peterson gap time model for analyzing recurrent events.

RESULTS

Over a median follow-up period of 41.3 months (interquartile range, 18.0-82.3 months), 253 (43.2%) patients experienced a total of 475 recurrences. Among the 1001 total transurethral resection procedures, BNI was observed in 122 (12.2%) cases. The 3-year cumulative recurrence rates of patients with and without BNI were 62.5% and 46.3%, respectively. Multivariable analysis revealed that number of tumors ≥ 4 (sub-hazard ratio [SHR], 1.48; P = .004), intravesical bacillus Calmette-Guérin therapy (SHR, 0.44; P < .001), and BNI (SHR, 1.59; P = .004) were all independent predictors of recurrence. Assigning 1 point for each of these 3 predictive factors, the resulting scores enabled us to classify patients into 3 prognostic groups that were clearly stratified according to recurrence.

CONCLUSIONS

Our time-dependent covariate analysis shows that BNI is a significant risk factor for recurrence in NMIBC. Our prognostic model incorporating BNI is an easy means of estimating recurrence risk and determining optimal management for individual patients.

摘要

背景

膀胱颈部肿瘤位置被报道为非肌肉浸润性膀胱癌(NMIBC)的预后因素。我们通过时间依赖性协变量分析研究了膀胱颈部受累(BNI)对 NMIBC 复发的影响。

患者和方法

我们招募了 585 名 2000 年至 2016 年在一家中心接受经尿道膀胱肿瘤切除术的日本患者,这些患者经病理诊断为 Ta 和 T1 NMIBC。根据分析复发性事件的 Prentice-Williams-Peterson 间隙时间模型,每位患者在每次复发时都被分配到一个单独的时间依赖性分层,该分层具有自己的基线风险函数。

结果

在中位随访 41.3 个月(四分位间距,18.0-82.3 个月)期间,253 名(43.2%)患者共发生 475 次复发。在总共 1001 次经尿道切除术程序中,观察到 122 例(12.2%)存在 BNI。有和没有 BNI 的患者 3 年累积复发率分别为 62.5%和 46.3%。多变量分析显示肿瘤数量≥4(亚危险比 [SHR],1.48;P=0.004)、膀胱内卡介苗治疗(SHR,0.44;P<0.001)和 BNI(SHR,1.59;P=0.004)都是复发的独立预测因素。将这 3 个预测因素中的每个因素赋值 1 分,所得分数使我们能够将患者分为 3 个预后组,这些组根据复发情况进行了明确分层。

结论

我们的时间依赖性协变量分析表明,BNI 是 NMIBC 复发的重要危险因素。我们的包含 BNI 的预后模型是一种简单的方法,可以估计复发风险并为个体患者确定最佳治疗方案。

相似文献

1
Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model.基于时依模型的膀胱癌非肌层浸润患者膀胱颈部侵犯与复发的相关性分析
Clin Genitourin Cancer. 2020 Apr;18(2):e62-e70. doi: 10.1016/j.clgc.2019.10.005. Epub 2019 Oct 16.
2
Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer.膀胱颈侵犯对中危非肌层浸润性膀胱癌风险分层的意义。
Eur Urol Focus. 2021 Mar;7(2):366-372. doi: 10.1016/j.euf.2020.01.006. Epub 2020 Jan 25.
3
Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: a prospective validation study.膀胱颈受累对原发性非肌层浸润性膀胱癌患者疾病进展的影响:一项前瞻性验证研究。
Urol Oncol. 2014 Jan;32(1):38.e29-36. doi: 10.1016/j.urolonc.2013.04.001. Epub 2013 May 20.
4
Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.经常复发的非肌肉浸润性膀胱癌患者行围手术期单次加每周 4 次丝裂霉素 C 灌注治疗,随后每月行卡介苗(BCG)或 BCG 与干扰素-α2b 交替灌注治疗的长期预后:前瞻性随机 FinnBladder-4 研究。
Eur Urol. 2015 Oct;68(4):611-7. doi: 10.1016/j.eururo.2015.02.022. Epub 2015 Mar 5.
5
Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer.卡介苗-Tice 与卡介苗-Moreau 治疗非肌层浸润性膀胱癌的疗效比较。
Clin Genitourin Cancer. 2020 Feb;18(1):20-25.e2. doi: 10.1016/j.clgc.2019.10.021. Epub 2019 Nov 6.
6
Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.经尿道治疗非肌肉浸润性膀胱癌:系统评价和荟萃分析。
J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24.
7
Construction of predictive models for recurrence and progression in >1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre.对单一中心 >1000 例非肌肉浸润性膀胱癌(NMIBC)患者的复发和进展进行预测模型的构建。
BJU Int. 2013 Jun;111(8):E331-41. doi: 10.1111/bju.12026. Epub 2013 Feb 27.
8
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.EORTC 列线图和风险分组用于预测非肌肉浸润性 Ta-T1 期尿路上皮膀胱癌患者接受 1-3 年卡介苗维持治疗后的复发、进展、疾病特异性和总生存情况。
Eur Urol. 2016 Jan;69(1):60-9. doi: 10.1016/j.eururo.2015.06.045. Epub 2015 Jul 23.
9
Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study.膀胱内卡介苗与表柔比星和α2a 干扰素联合应用降低非肌肉浸润性膀胱癌复发:FinnBladder-6 研究。
Eur Urol. 2016 Aug;70(2):341-7. doi: 10.1016/j.eururo.2016.03.034. Epub 2016 Apr 13.
10
Non-maintenance intravesical Bacillus Calmette-Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study.高风险或极高风险非肌层浸润性膀胱癌患者行 8 剂卡介苗非维持膀胱内诱导治疗:一项回顾性非随机对照研究。
BMC Cancer. 2021 Mar 11;21(1):266. doi: 10.1186/s12885-021-07966-7.

引用本文的文献

1
Recurrence risk prediction for non-muscle-invasive bladder urothelial carcinoma using diffusion and clinicopathology features.利用扩散及临床病理特征预测非肌层浸润性膀胱尿路上皮癌的复发风险
Abdom Radiol (NY). 2025 May 28. doi: 10.1007/s00261-025-05023-6.
2
Recent Advances and Emerging Innovations in Transurethral Resection of Bladder Tumor (TURBT) for Non-Muscle Invasive Bladder Cancer: A Comprehensive Review of Current Literature.非肌层浸润性膀胱癌经尿道膀胱肿瘤切除术(TURBT)的最新进展与新兴创新:当前文献综述
Res Rep Urol. 2025 Mar 14;17:69-85. doi: 10.2147/RRU.S386026. eCollection 2025.
3
The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries.
肿瘤位置对行经尿道膀胱肿瘤切除术的非肌层浸润性膀胱癌患者预后的影响:利用中国多中心和 SEER 登记处的队列研究得出的见解。
Int J Surg. 2024 Sep 1;110(9):5641-5651. doi: 10.1097/JS9.0000000000001675.
4
Prognostic significance of bladder neck involvement in non-muscle-invasive bladder cancer: A SEER database analysis with 19,919 patients.膀胱癌膀胱颈部侵犯的预后意义:基于 19919 例患者的 SEER 数据库分析。
Cancer Med. 2021 Oct;10(19):6868-6880. doi: 10.1002/cam4.4219. Epub 2021 Aug 23.
5
Extracellular Matrix-Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer.细胞外基质相关的六个长链非编码RNA特征作为膀胱癌的一种新型预后生物标志物
Onco Targets Ther. 2020 Dec 7;13:12521-12538. doi: 10.2147/OTT.S284167. eCollection 2020.